Allgenesis is a privately-held, clinical stage ophthalmology company based in Taiwan. The company is focused on novel multi-specific fusion proteins for treating diabetic macular edema and wet-age-related macular degeneration; and small molecule eye drops for dry eye and pterygium diseases.
Company Details
- Employees
- 9
- Founded
- -
- Address
- Taipei, Songshan 105, Tw
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- allgenesis.com
- Keywords
- ophthalmology, diabetic macular edema, wet age-related macular degeneration, pterygium, dry eye disease, Fc-fusion protein design.
- HQ
- Taipei, Songshan
Allgenesis Biotherapeutics Inc. Questions
Allgenesis Biotherapeutics Inc.'s website is allgenesis.com
Allgenesis Biotherapeutics Inc.'s LinkedIn profile is https://is.linkedin.com/company/allgenesis
Allgenesis Biotherapeutics Inc. has
9 employees.
View email and phone details for 9
employees at Allgenesis Biotherapeutics Inc..
Allgenesis Biotherapeutics Inc.'s industry is
Pharmaceutical Manufacturing
Allgenesis Biotherapeutics Inc.'s top competitors are
Boston Immune Technologies And Therapeutics,
Kaiser Pharmaceutical Co.,
Shogun Capital,
Prj Analytics,
Lexitas Pharma Services,
Advanced Bioscience,
北海康成(北京)医药科技有限公司,
Naples Luxury Imports,
Abir Analytics,
Alnylam Pharmaceuticals.
Allgenesis Biotherapeutics Inc.'s categories are Pharmaceutical Manufacturing
Allgenesis Biotherapeutics Inc.'s founding year is 2014
